We are live on ! Find out more
RCG

Rock Creek Group Portfolio holdings

AUM $994M
1-Year Est. Return 11.29%
This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+11.29%
3 Year Est. Return
+37.19%
5 Year Est. Return
+44.62%
10 Year Est. Return
AUM
$735M
AUM Growth
+$62.4M
Cap. Flow
+$48.3M
Cap. Flow %
6.57%
Top 10 Hldgs %
70.29%
Holding
242
New
34
Increased
73
Reduced
60
Closed
63

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.17%
2 Consumer Discretionary 21.3%
3 Technology 5.24%
4 Industrials 3.88%
5 Financials 2.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
201
Morgan Stanley
MS
$318B
-1,582
Closed -$155K
MXCT icon
202
MaxCyte
MXCT
$122M
-52,684
Closed -$340K
NEE icon
203
NextEra Energy
NEE
$168B
-1,374
Closed -$128K
PAR icon
204
PAR Technology
PAR
$666M
-8,797
Closed -$464K
PIII icon
205
P3 Health Partners
PIII
$29.8M
-1,523
Closed -$406K
PODD icon
206
Insulet
PODD
$9.75B
-3,748
Closed -$930K
RGEN icon
207
Repligen
RGEN
$9.76B
-3,370
Closed -$668K
RILY icon
208
BRC Group Holdings
RILY
$242M
-8,281
Closed -$736K
SDGR icon
209
Schrodinger
SDGR
$1.79B
-10,466
Closed -$297K
SE icon
210
Sea Limited
SE
$63.4B
-7,300
Closed -$1.63M
SKIN icon
211
SkinHealth Systems
SKIN
$87.8M
-8,682
Closed -$123K
T icon
212
AT&T
T
$177B
-12,767
Closed -$237K
TGTX icon
213
TG Therapeutics
TGTX
$8.55B
-26,606
Closed -$308K
TIL icon
214
Instil Bio
TIL
$48.7M
-1,740
Closed -$404K
TIPT icon
215
Tiptree Inc
TIPT
$653M
-75,000
Closed -$1.04M
TJX icon
216
TJX Companies
TJX
$135B
-138
Closed -$10K
TKNO icon
217
Alpha Teknova
TKNO
$382M
-26,087
Closed -$412K
TMO icon
218
Thermo Fisher Scientific
TMO
$240B
-526
Closed -$351K
TWST icon
219
Twist Bioscience
TWST
$9.49B
-9,125
Closed -$542K
VEEV icon
220
Veeva Systems
VEEV
$42.9B
-2,041
Closed -$483K
VERV
221
DELISTED
Verve Therapeutics
VERV
-13,303
Closed -$383K
VTGN icon
222
VistaGen Therapeutics
VTGN
$10.2M
-5,386
Closed -$263K
XOM icon
223
ExxonMobil
XOM
$672B
-4,462
Closed -$273K
XPEV icon
224
XPeng
XPEV
$9.89B
-635
Closed -$32K
NBIS
225
Nebius Group N.V.
NBIS
$56.9B
$0 ﹤0.01%
119,080
+80,012
+205% +$3.8M

Similar funds

Rock Creek Group's Q1 2022 Portfolio in Review

As of Q1 2022, Rock Creek Group held 242 positions worth $735M, up 9.3% from $673M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Rock Creek Group deployed $48.3M of net new capital in Q1 2022, opening 34 new positions and adding to 73 existing holdings. Its largest new stake was iShares MSCI Chile ETF: 2,001,889 shares worth $57.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 64% of assets, down from 69% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $37.4M trimmed.

  • Rock Creek Group's largest Q1 2022 buy was iShares MSCI Chile ETF: 2,001,889 shares worth $57.9M.
  • Rock Creek Group added most to Choice Hotels in Q1 2022, an estimated $92.3M increase.
  • Rock Creek Group's biggest Q1 2022 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $37.4M.
  • Rock Creek Group fully exited iShares MSCI India ETF in Q1 2022, selling an estimated $59.7M.
  • Rock Creek Group's ten largest holdings make up 70% of its $735M portfolio in Q1 2022.
  • Rock Creek Group opened 34 new positions and closed 63 in Q1 2022.
  • Rock Creek Group's portfolio value rose 9.3% quarter-over-quarter to $735M.

Based on Rock Creek Group's 13F filing for Q1 2022, filed 11 May 2022.